Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
women with a migraine post image
blog

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

While these drugs offer relief for migraine sufferers, what are the efficacy and cost considerations for injured workers?
Read More
rxinformer

Ask a Clinician: What Do I need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME).
Read More
MAC Monitor and magazine cover graphic
INDUSTRY SURVEY

2024 Industry Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

Imuldosa Approved as Stelara® Biosimilar

This drug has been approved for the treatment of multiple chronic inflammatory disorders.

Nov 2024

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.

Nov 2024

Are Migraine Drugs Driving Up Pharmacy Spend?

Recent data from CWCI and WCRI, plus clinical concerns.

Nov 2024

Minnesota Invites the Public to Complete a PTSD Survey

As part of a legislative-mandated study on work-related PTSD, the survey could influence regulator objectives for 2025.

Nov 2024

Could Psychedelic Injections Help with Mental Illness While Avoiding Hallucinogenic Effects?

A recent study involving the compound DOI showed promising results in mice.

Nov 2024

The Impact of Adverse Weather on Workers’ Comp Claims

A new NCCI report found that hotter and colder temperatures were associated with higher claims frequency, as much as 10% higher in some cases.

Nov 2024

FDA Considers Policy Changes for GLP-1 Compounds

Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.

Oct 2024

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

Healthes’ AVP of Information Security, Tony Brown, discusses how cyber threats affect workers’ comp organizations.

Oct 2024

New Opioid Prescribing and Abuse Data

NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.

Oct 2024

Dermatologicals Continue to See Increases in Utilization

WCRI reports for Delaware and Philadelphia reported increases, matching patterns seen previously in other states.

Oct 2024

New York Allows Physical and Occupational Therapy Assistants to Treat Injured Workers

These assistants must be under the supervision of a board-authorized provider.

Oct 2024

Thought Leadership from Healthesystems

A new issue of RxInformer magazine, plus Leaders Speak posts in WorkCompWire, featuring Sandy Shtab and Silvia Sacalis.

Oct 2024

Sleep Woes: Fatigue in the Workplace

Sleep deprivation and fatigue have far-reaching consequences in the workplace, from poor productivity to injury or death.

Winter 2024-25

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

RxInformer editors sat down with Healthesystems’ AVP of Information Security and resident cybersecurity expert, Tony Brown, to discuss how cyber threats affect workers’ comp organizations.

Winter 2024-25

From A-to-Z: 5 Population Considerations for Gen Z

Health trends in Gen Z to consider in this growing portion of the workforce.

Winter 2024-25

Drug Pricing Legislation and Its Impact on Workers' Comp

Lawmakers look to regulate the U.S. drug supply chain in ways that could impact workers’ comp pharmacy management.

Winter 2024-25

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases

Winter 2024-25

High Prices, High Impact: Meet the Drugs Driving Up Claim Costs in Workers’ Comp

High-impact drugs, including topicals and compounds, represent proportionately low utilization compared to opioids or NSAIDs, but they can increase pharmacy spend exponentially on impacted claims.

Winter 2024-25

State of the Nation

A roundup of regulatory activity around the country

Winter 2024-25

FDA Approves Zurnai and Neffy

FDA Approves Zurnai and Neffy

Sep 2024

Removing Barriers to Recovery: A Primer on Psychosocial Treatments for Injured Workers

The benefits of different screening strategies and therapeutic interventions.

Sep 2024

Congress Urges USPS to Adopt Department of Labor’s Proposed Heat Protections

The push comes after a letter carrier died after working without air conditioning in 95° weather.

Sep 2024

FDA Rejects MDMA for PTSD – Clinical Research to Continue for Psychedelics

The FDA requested additional trial data, with researchers eager to continue psychedelic trials.

Sep 2024

WCRI Reports on Factors Associated with High-Cost Claims

High-cost claims are defined as the top 5% of medical payments within 36 months of injury.

Sep 2024

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2024!

Stop by our educational session or visit our booth for the latest issue of RxInformer magazine.

Sep 2024

6 Complexities in Workers’ Comp Claims – and How to Address Them

Let’s look at common complexities in workers’ comp claims – and how a combination of technology, data, and people can help address them.

Sep 2024

A Weighty Matter: Obesity and Workers’ Compensation

Obesity has many implications for injured workers, from being a catalyst for injuries to increasing healthcare costs and lengthening time away from work.

Sep 2024

Recalls and Alerts Impacting Workers’ Comp

The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.

Aug 2024

Weighing the Options: Keeping Track of New Obesity Drugs

Comorbid obesity can complicate recovery, and new drugs create new pharmacy considerations.

Aug 2024

Worker Heat Protections Continue to Make Waves

The U.S. Department of Labor proposed new rules, while other states introduce legislation.

Aug 2024

1 2 3 4 5 18 19 20 21 22
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle